Isotretinoin | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Isotretinoin
Health Canada Patents

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

Contact Supplier

Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

Contact Supplier

Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.

Contact Supplier

Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Contact Supplier

Isotretinoin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 15 USDMF, 10 CEP/COS, 2 EU WC, 3 KDMF, 7 NDC API, 14 Listed Suppliers, $ API Reference Price

31 API Suppliers
15 USDMF
10 CEP/COS
2 EU WC
3 KDMF
7 NDC API
14 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

51 Drugs in Development

51 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

213 FDF Dossiers, 65 FDA Orange Book, 70 Europe, 12 Canada, 18 Australia, 16 South Africa, 32 Listed Dossiers

213 FDF Dossiers
65 FDA Orange Book
70 Europe
12 Canada
18 Australia
16 South Africa
32 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 10MG, CAPSULE;ORAL - 20MG, CAPSULE;ORAL - 25MG, CAPSULE;ORAL - 30MG, CAPSULE;ORAL - 35MG, CAPSULE;ORAL - 40MG

CAPSULE;ORAL - 10MG
CAPSULE;ORAL - 20MG
CAPSULE;ORAL - 25MG
CAPSULE;ORAL - 30MG
CAPSULE;ORAL - 35MG
CAPSULE;ORAL - 40MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 1 Rochem International Inc, 3 SPI Pharma, 10 DKSH, 1 Boai NKY Pharmaceuticals Ltd, 1 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 4 ACG Worldwide, 4 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 17 BASF, 1 Finar, 7 Gangwal Chemicals, 3 Lonza Capsugel, 2 Microlex e.U, 2 Nanjing Bold Chemical, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 1 Qualicaps, 11 Roquette, 9 Seppic, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

2 EUROAPI
1 Minakem
1 Rochem International Inc
3 SPI Pharma
10 DKSH
1 Boai NKY Pharmaceuticals Ltd
1 Gangwal Healthcare
5 Nanjing Well Pharmaceutical
2 Kirsch Pharma
4 ACG Worldwide
4 Actylis
1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
1 Ashland
17 BASF
1 Finar
7 Gangwal Chemicals
3 Lonza Capsugel
2 Microlex e.U
2 Nanjing Bold Chemical
1 Novo Excipients
1 Pharmatrans-Sanaq
3 Pluviaendo
1 Qualicaps
11 Roquette
9 Seppic
1 Shijiazhuang Huaxu Pharmaceutical
1 Sigachi Industries
1 Valens Pharmachem
1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

22 Solubilizers, 18 Parenteral, 17 Fillers, Diluents & Binders, 15 Film Formers & Plasticizers, 13 Thickeners and Stabilizers, 12 Topical, 11 Coating Systems & Additives, 10 Emulsifying Agents, 8 Direct Compression, 8 Empty Capsules, 8 Granulation, 7 Taste Masking, 6 Surfactant & Foaming Agents, 4 Controlled & Modified Release, 4 Lubricants & Glidants, 3 Coloring Agents, 3 Co-Processed Excipients, 3 API Stability Enhancers, 2 Rheology Modifiers, 2 Chewable & Orodispersible Aids, 1 Soft Gelatin, 1 Disintegrants & Superdisintegrants

22 Solubilizers
18 Parenteral
17 Fillers, Diluents & Binders
15 Film Formers & Plasticizers
13 Thickeners and Stabilizers
12 Topical
11 Coating Systems & Additives
10 Emulsifying Agents
8 Direct Compression
8 Empty Capsules
8 Granulation
7 Taste Masking
6 Surfactant & Foaming Agents
4 Controlled & Modified Release
4 Lubricants & Glidants
3 Coloring Agents
3 Co-Processed Excipients
3 API Stability Enhancers
2 Rheology Modifiers
2 Chewable & Orodispersible Aids
1 Soft Gelatin
1 Disintegrants & Superdisintegrants

DIGITAL CONTENT

31 News #PharmaBuzz

31 News #PharmaBuzz

GLOBAL SALES INFORMATION

13 US Medicaid Prescriptions, 70 Regulatory FDF Prices

13 US Medicaid Prescriptions
70 Regulatory FDF Prices

MARKET PLACE

25 APIs, 4 FDF Dossiers

25 APIs
4 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 US Patents, 4 Health Canada Patents

12 US Patents
4 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 3 Others

3 EDQM
3 Others

$ API Ref.Price (USD/KG) : 2,025 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Sun Pharma Canada Inc.

filter Patent Reset all filters

4 All

01 42963206

filter Product Reset all filters

4 All

01 4ISOTRETINOIN

filter Dosage Reset all filters

4 All

01 4CAPSULE

filter Exp Date Reset all filters

4 All

01 42035-05-29

Product Main Page

01

Sun Pharma Canada Inc.

ISOTRETINOIN

World Drug Safety EU

Not Confirmed

Sun Pharma Canada Inc.

Country

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-05-29

Date Granted : 2023-09-26

ISOTRETINOIN

Brand Name : ABSORICA LD

Patent Number : 2963206

Filing Date : 2015-05-29

Strength per Unit : 8 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2035-05-29

Date Granted : 2023-09-26

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Sun Pharma Canada Inc.

ISOTRETINOIN

World Drug Safety EU

Not Confirmed

Sun Pharma Canada Inc.

Country

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-05-29

Date Granted : 2023-09-26

ISOTRETINOIN

Brand Name : ABSORICA LD

Patent Number : 2963206

Filing Date : 2015-05-29

Strength per Unit : 16 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2035-05-29

Date Granted : 2023-09-26

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Sun Pharma Canada Inc.

ISOTRETINOIN

World Drug Safety EU

Not Confirmed

Sun Pharma Canada Inc.

Country

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-05-29

Date Granted : 2023-09-26

ISOTRETINOIN

Brand Name : ABSORICA LD

Patent Number : 2963206

Filing Date : 2015-05-29

Strength per Unit : 24 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2035-05-29

Date Granted : 2023-09-26

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Sun Pharma Canada Inc.

ISOTRETINOIN

World Drug Safety EU

Not Confirmed

Sun Pharma Canada Inc.

Country

World Drug Safety EU

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-05-29

Date Granted : 2023-09-26

ISOTRETINOIN

Brand Name : ABSORICA LD

Patent Number : 2963206

Filing Date : 2015-05-29

Strength per Unit : 32 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2035-05-29

Date Granted : 2023-09-26

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!